companiesandmarkets.com

Return to Report | Print

Premium Company Profile - Elan Corporation plc

http://www.companiesandmarkets.com/Summary-Company-Profile/premium-company-profile-elan-corporation-plc-41223.asp

Report Summary

Introduction

Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing therapies in neurodegenerative diseases, autoimmune diseases, and severe pain. The company currently markets anti-infectives Maxipime and Azactam, as well as Tysabri, its landmark product co-developed with Biogen Idec.

During fiscal 2006, Elan generated approximately 51% of total revenues from EDT division and 49% from biopharmaceuticals division. The company earns revenues from product sales, royalties and licenses. Elan now has a balanced contribution from product sales and royalties, licenses, collaboration and other.

Tysabri is expected to be the main growth driver of revenues for Elan to 2010, generating sales growth of +$1,832 million during the period 2006-2010. Currently, Tysabri is indicated for the treatment for relapsing forms of multiple sclerosis (MS). The drug is currently in Phase III clinical trial for Crohn’s Disease.

Scope

  • Access all the important information and analysis on a company in a single report
  • Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company’s adjusted five year financial data along with key ratios and market capitalization


    • Highlights



    Reasons to Purchase

    Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 8
    Locations and Subsidiaries 11
    Company Financials 12
    Stock Market Performance 12
    P&L 13
    Balance Sheet 15
    Cash Flow 15
    Business Segment Performance 16
    Geographic Segment Performance 16
    Products & Services 18
    Marketed Products 18
    Pipeline Products 19
    Historical Product Sales 21
    AC Forecast Product Sales 23
    Competitors and Strategic Business Relationships 25
    Top Competitors 25
    Key Suppliers 25
    Key Clients 25
    Shareholding Structure 27
    Strategy 28
    Company View 28
    Strategy 29
    SWOT Analysis 31
    Overview 31
    Strengths 32
    Weaknesses 33
    Opportunities 34
    Threats 35
    Value Chain Analysis 37
    Overview 37
    Scorecard 39
    Overview 39
    Scorecard Analysis 40
    Key Employees 41
    Key Employee Biographies 42
    Financial and Operational Overview 52
    Financial and Operational Overview 52
    Appendix 55
    Ask the analyst 55
    Datamonitor consulting 55
    Disclaimer 55


    TABLE OF FIGURES
    Figure 1: Elan - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
    Figure 2: Elan - Key Strategic Revenues, 2002-2006 ($ Mn) 22
    Figure 3: Elan - Key Strategic Revenues, 2006-2010 ($ Mn) 24


    TABLE OF TABLES
    Table 1: Elan - Key Facts 7
    Table 2: Elan – Locations and Subsidiaries 12
    Table 3: Elan - Year-End Share Price and Market Capitalization, 2002-2006 ($) 13
    Table 4: Elan - Key Events Impacting Share Price Performance 13
    Table 5: Elan - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
    Table 6: Elan - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 16
    Table 7: Elan - Balance Sheet, 2002-2006 ($ Mn) 16
    Table 8: Elan - Cash Flow, 2002-2006 ($ Mn) 16
    Table 9: Elan - Revenue Breakdown, 2002-2006 ($ Mn) 17
    Table 10: Elan - Geographic Breakdown, 2002-2006 ($ Mn) 18
    Table 11: Elan - Marketed Products 19
    Table 12: Elan - In-house Pipeline Products 20
    Table 13: Elan - Collaboration Pipeline Products 21
    Table 14: Elan - Historical Product Sales, 2002-2006 ($ Mn) 22
    Table 15: Elan - Forecast Sales, 2006-2010 ($ Mn) 24
    Table 16: Elan - Top Competitors 26
    Table 17: Elan - Key Suppliers 26
    Table 18: Elan - Key Clients 27
    Table 19: Elan - Key Shareholders 28
    Table 20: Elan - SWOT Analysis Summary 32
    Table 21: Elan – Value Chain Analysis 38
    Table 22: Elan - Scorecard 40
    Table 23: Elan - Key Employees 42
    Table 24: Elan – Financial and Operational Overview 54